EyePoint Pharmaceuticals
EYPT
EYPT
32 hedge funds and large institutions have $50.7M invested in EyePoint Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
36% less funds holding
Funds holding: 50 → 32 (-18)
69% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 26
Holders
32
Holding in Top 10
1
Calls
$240K
Puts
$14K
Top Buyers
| 1 | +$6.58M | |
| 2 | +$4.61M | |
| 3 | +$602K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$186K |
| 5 |
Millennium Management
New York
|
+$163K |
Top Sellers
| 1 | -$816K | |
| 2 | -$87.8K | |
| 3 | -$79.6K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$75.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$72.9K |